These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34307446)

  • 1. Inactivation of Cerebral Cavernous Malformation Genes Results in Accumulation of von Willebrand Factor and Redistribution of Weibel-Palade Bodies in Endothelial Cells.
    Much CD; Sendtner BS; Schwefel K; Freund E; Bekeschus S; Otto O; Pagenstecher A; Felbor U; Rath M; Spiegler S
    Front Mol Biosci; 2021; 8():622547. PubMed ID: 34307446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precise CCM1 gene correction and inactivation in patient-derived endothelial cells: Modeling Knudson's two-hit hypothesis in vitro.
    Spiegler S; Rath M; Much CD; Sendtner BS; Felbor U
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00755. PubMed ID: 31124307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial Differentiation of
    Pilz RA; Skowronek D; Mellinger L; Bekeschus S; Felbor U; Rath M
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative trafficking of Weibel-Palade body proteins in CRISPR/Cas9-engineered von Willebrand factor-deficient blood outgrowth endothelial cells.
    Schillemans M; Kat M; Westeneng J; Gangaev A; Hofman M; Nota B; van Alphen FPJ; de Boer M; van den Biggelaar M; Margadant C; Voorberg J; Bierings R
    Res Pract Thromb Haemost; 2019 Oct; 3(4):718-732. PubMed ID: 31624792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weibel-Palade Body Localized Syntaxin-3 Modulates Von Willebrand Factor Secretion From Endothelial Cells.
    Schillemans M; Karampini E; van den Eshof BL; Gangaev A; Hofman M; van Breevoort D; Meems H; Janssen H; Mulder AA; Jost CR; Escher JC; Adam R; Carter T; Koster AJ; van den Biggelaar M; Voorberg J; Bierings R
    Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1549-1561. PubMed ID: 29880488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the storage and secretion of von Willebrand factor in blood outgrowth endothelial cells derived from patients with von Willebrand disease.
    Wang JW; Bouwens EA; Pintao MC; Voorberg J; Safdar H; Valentijn KM; de Boer HC; Mertens K; Reitsma PH; Eikenboom J
    Blood; 2013 Apr; 121(14):2762-72. PubMed ID: 23426949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR/Cas9-mediated Generation of Human Endothelial Cell Knockout Models of CCM Disease.
    Schwefel K; Spiegler S; Much CD; Felbor U; Rath M
    Methods Mol Biol; 2020; 2152():169-177. PubMed ID: 32524552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin rescues aberrant phenotype of endothelial cells lacking either CCM1, CCM2 or CCM3.
    Schwefel K; Spiegler S; Kirchmaier BC; Dellweg PKE; Much CD; Pané-Farré J; Strom TM; Riedel K; Felbor U; Rath M
    FASEB J; 2020 Jul; 34(7):9018-9033. PubMed ID: 32515053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using CRISPR/Cas9 genome editing in human iPSCs for deciphering the pathogenicity of a novel
    Pilz RA; Skowronek D; Hamed M; Weise A; Mangold E; Radbruch A; Pietsch T; Felbor U; Rath M
    Front Mol Biosci; 2022; 9():953048. PubMed ID: 36090026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postzygotic mosaicism in cerebral cavernous malformation.
    Rath M; Pagenstecher A; Hoischen A; Felbor U
    J Med Genet; 2020 Mar; 57(3):212-216. PubMed ID: 31446422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic causes of multiple cerebral cavernous malformations in a Japanese population.
    Tsutsumi S; Ogino I; Miyajima M; Ikeda T; Shindo N; Yasumoto Y; Ito M; Arai H
    J Clin Neurosci; 2013 May; 20(5):667-9. PubMed ID: 23485406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial cerebral cavernous malformation presenting with epilepsy caused by mutation in the CCM2 gene: A case report.
    Ishii K; Tozaka N; Tsutsumi S; Muroi A; Tamaoka A
    Medicine (Baltimore); 2020 Jul; 99(29):e19800. PubMed ID: 32702807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complex.
    Stahl S; Gaetzner S; Voss K; Brackertz B; Schleider E; Sürücü O; Kunze E; Netzer C; Korenke C; Finckh U; Habek M; Poljakovic Z; Elbracht M; Rudnik-Schöneborn S; Bertalanffy H; Sure U; Felbor U
    Hum Mutat; 2008 May; 29(5):709-17. PubMed ID: 18300272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial cells evade complement-mediated membrane injury via Weibel-Palade body mobilization.
    Riedl Khursigara M; Schlam D; Noone DG; Bruno V; Ortiz-Sandoval CG; Pluthero FG; Kahr WHA; Bowman ML; James P; Grinstein S; Licht C
    J Thromb Haemost; 2020 Jun; 18(6):1484-1494. PubMed ID: 32073731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective AP-3-dependent VAMP8 trafficking impairs Weibel-Palade body exocytosis in Hermansky-Pudlak Syndrome type 2 blood outgrowth endothelial cells.
    Karampini E; Schillemans M; Hofman M; van Alphen F; de Boer M; Kuijpers TW; van den Biggelaar M; Voorberg J; Bierings R
    Haematologica; 2019 Oct; 104(10):2091-2099. PubMed ID: 30630984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells.
    Pagenstecher A; Stahl S; Sure U; Felbor U
    Hum Mol Genet; 2009 Mar; 18(5):911-8. PubMed ID: 19088124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
    McDonald DA; Shenkar R; Shi C; Stockton RA; Akers AL; Kucherlapati MH; Kucherlapati R; Brainer J; Ginsberg MH; Awad IA; Marchuk DA
    Hum Mol Genet; 2011 Jan; 20(2):211-22. PubMed ID: 20940147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel
    Wang K; Wu D; Zhang B; Zhao G
    Front Neurol; 2018; 9():1128. PubMed ID: 30622508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of the angiogenic phenotype and genotype of the endothelia derived from sporadic cerebral cavernous malformations.
    Zhu Y; Wu Q; Fass M; Xu JF; You C; Müller O; Sandalcioglu IE; Zhang JM; Sure U
    Neurosurgery; 2011 Sep; 69(3):722-31; discussion 731-2. PubMed ID: 21471841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.
    Gault J; Sain S; Hu LJ; Awad IA
    Neurosurgery; 2006 Dec; 59(6):1278-84; discussion 1284-5. PubMed ID: 17277691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.